340B hospitals are bracing for a blow tomorrow when drug manufacturer Merck imposes restrictions on 340B discounts when hospitals use contract pharmacies to dispense drugs to patients.
Merck’s 340B contract pharmacy limitations will come on the heels of Boehringer Ingelheim’s (BI’s) decision effective Aug. 1 to deny 340B pricing on its products when hospitals contract with pharmacies to dispense the medicines.
340B hospitals are bracing for a blow tomorrow when drug manufacturer Merck imposes restrictions on 340B discounts when entities use contract pharmacies to dispense drugs to patients.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
